Sleep disturbance in the patients with severe spasticity and its improvement by intrathecal baclofen therapy
-
- Nomura Sadahiro
- Department of Neurosurgery, Yamaguchi University School of Medicine Epilepsy Center, Yamaguchi University Hospital
-
- Fujii Natsumi
- Department of Neurosurgery, Yamaguchi University School of Medicine Epilepsy Center, Yamaguchi University Hospital
-
- Imoto Hirochika
- Department of Neurosurgery, Yamaguchi University School of Medicine Epilepsy Center, Yamaguchi University Hospital
-
- Fujituku Shunsuke
- Department of Neurosurgery, Yamaguchi University School of Medicine Epilepsy Center, Yamaguchi University Hospital
-
- Ishihara Hideyuki
- Department of Neurosurgery, Yamaguchi University School of Medicine
Bibliographic Information
- Other Title
-
- 重症痙縮に伴う睡眠障害と髄腔内バクロフェン療法による改善
Abstract
<p>Purpose: Patients with severe spasticity caused by cerebral palsy suffer from sleep disturbance. Intrathecal baclofen (ITB) therapy releases spasticity; thus, may result to a deep sleep. We measured the sleep pattern of patients with severe spasticity before and after ITB therapy induction.</p><p>Methods: Four patients with cerebral palsy (boys aged 10, 13, and 18 years and a woman aged19 years) and two adults with head trauma and stroke participated in the study. All patients presented persistent consciousness disturbance and spastic tetrapalsy with level V in gross motor function classification system. ITB system was implanted in all patients and degrees of pre - and postoperative modified Ashworth scale (mAS) was scored. Total and deep sleep durations were analyzed by motion, heart rate, and heart rate variability using a sports watch mounting acceleration meter and heart rate meter. The measurements were performed overnight 1 day before and 7 days after ITB therapy induction.</p><p>Results: Doses of baclofen were adjusted at 70-200 µg/day. Spasticity scored by mAS significantly decreased from 2.85 ± 0.12 to 2.31 ± 0.36 (p = 0.014). Average total and deep sleep durations preoperatively were 7 h 26 m ± 3 h 3 m and 30 m ± 34 m, which were shorter than the sleep durations of the same age group of healthy individuals. Total and deep sleep durations under the ITB therapy significantly increased to 8 h 48 m ± 2 h 17 m (p = 0.04) and 1 h 8 m ± 2 h 47 m (p = 0.03).</p><p>Conclusion: In patients with severe spasticity, sleep was a disturbance that may be improved by ITB therapy. Sleep duration and depth, as well as mAS, could serve as good indicators for adjusting the optimal ITB dose.</p>
Journal
-
- Nervous System in Children
-
Nervous System in Children 49 (1), 13-17, 2024
The Japanese Society for Pediatric Neurosurgery
- Tweet
Keywords
Details 詳細情報について
-
- CRID
- 1390862732250375296
-
- ISSN
- 2435824X
- 03878023
-
- Text Lang
- ja
-
- Data Source
-
- JaLC
-
- Abstract License Flag
- Disallowed